DBV Technologies. (DBVT) NASDAQ
$0.58 (0.01) (-2.24%)
Market Cap: $111.15M
As of 05/15/24 04:00 PM EDT. Market closed.
DBV Technologies. (DBVT)
NASDAQ
$0.58
(0.01) (-2.24%)
Market Cap: $111.15M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
dbv technologies is opening up a decisive new approach to the treatment of allergy – a major public health issue that is constantly increasing in prevalence. food allergies represent a true handicap in everyday life for millions of people and thus constitute a major unmet medical need. dbv technologies (incorporated in 2002) has developed a unique, proprietary, worldwide-patented technology for ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Daniel Tasse
Address
177-181 avenue Pierre Brossolette, Ile De France, Montrouge, 92120.
PRICE CHART FOR DBV TECHNOLOGIES
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.60
Previous Close
$0.59
Days Range
$0.56 - $0.61
52 week range
$0.42 - $2.26
Volume
101,397
Avg. Volume (30 days)
69,615
Market Cap
$111.15M
Dividend Yield
-
P/E
-
Shares Outstanding
192,868,738
Open
$0.60
Previous Close
$0.59
Days Range
$0.56 - $0.61
52 week range
$0.42 - $2.26
Volume
101,397
Avg. Volume (30 days)
69,615
Market Cap
$111.15M
Dividend Yield
-
P/E
-
Shares Outstanding
192,868,738
FINANCIAL STATEMENTS FOR DBV TECHNOLOGIES
LOADING...
INSIDER TRANSACTIONS FOR DBV TECHNOLOGIES
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Tasse Daniel | CHIEF EXECUTIVE OFFICER | Mar 08, 2024 | Buy | $0.83 | 17,094 | 14,188 | 17,094 | Mar 11, 2024, 04:15 PM |
Ndu Adora | Director | Feb 06, 2024 | Buy | $0.89 | 1,825 | 1,624 | 1,825 | Feb 08, 2024, 05:02 PM |
Mohideen Pharis | Chief Medical Officer | Nov 22, 2023 | Sale | $1.74 | 2,245 | 3,906 | 82,194 | Dec 19, 2023, 04:44 PM |
MORRIS TIMOTHY E | Director | Aug 25, 2023 | Buy | $1.52 | 12,000 | 18,240 | 12,000 | Aug 28, 2023, 04:35 PM |
Mohideen Pharis | Chief Medical Officer | May 24, 2023 | Sale | $3.54 | 469 | 1,660 | 49,439 | Aug 14, 2023, 04:32 PM |
Mohideen Pharis | Chief Medical Officer | Nov 24, 2022 | Sale | $2.88 | 1,792 | 5,161 | 49,908 | Aug 14, 2023, 04:32 PM |
SOLAND DANIEL B | Director | Aug 01, 2023 | Buy | $1.62 | 15,000 | 24,300 | 20,000 | Aug 03, 2023, 04:40 PM |
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Tasse Daniel | CHIEF EXECUTIVE OFFICER | 03/08/2024 | 14,188 |
Ndu Adora | Director | 02/06/2024 | 1,624 |
Mohideen Pharis | Chief Medical Officer | 11/22/2023 | 3,906 |
MORRIS TIMOTHY E | Director | 08/25/2023 | 18,240 |
Mohideen Pharis | Chief Medical Officer | 05/24/2023 | 1,660 |
Mohideen Pharis | Chief Medical Officer | 11/24/2022 | 5,161 |
SOLAND DANIEL B | Director | 08/01/2023 | 24,300 |
FUNDS WITH A POSITION IN DBV TECHNOLOGIES
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 14,614,264 | 0.14% | No change | Other |
YIHENG CAPITAL MANAGEMENT, L.P. | 5,568,909 | 0.23% | 6.25% | Other |
VIVO CAPITAL, LLC | 2,708,875 | 0.16% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 38,779 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR DBV TECHNOLOGIES
STOCK BUYBACKS FOR DBV TECHNOLOGIES
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.01%
1Q
06/30/2023
1.86%
2Q
03/31/2023
2.25%
3Q
12/31/2022
24.16%
4Q
09/30/2022
2.32%
5Q
06/30/2022
45.47%
6Q
03/31/2022
74.91%
7Q
12/31/2021
74.90%
8Q
09/30/2021
74.86%
9Q
06/30/2021
75.00%
10Q
03/31/2021
75.07%
11Q
12/31/2020
75.28%
12Q
09/30/2020
75.19%
13Q
06/30/2020
75.09%
14Q
03/31/2020
85.48%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DBV TECHNOLOGIES
LOADING...